Cited by 100Mast cells and histamineAsthma and respiratory diseasesAllergic Rhinitis and Sensitization

FcϵRI-mediated thymic stromal lymphopoietin production by interleukin-4-primed human mast cells

Open access
Okayama, Y., Okumura, S., Sagara, H., Yuki, K., Sasaki, T., Watanabe, N., Fueki, M., Sugiyama, K. +4 more·2009·European Respiratory Journal

Abstract

A significant increase of mRNA expression of thymic stromal lymphopoietin (TSLP) has been reported in the bronchial mast cells (MCs) of asthmatic subjects; however, the mechanism underlying the upregulation of TSLP mRNA and protein remains unknown. FcϵRI-mediated activation of human MCs upregulated TSLP mRNA expression by 5.2±2.9-fold, while activation of the MCs using lipopolysaccharide and polyriboinosinic:polyribocytidylic acid failed to upregulate TSLP. Stimulation of MCs with interleukin (IL)-4 alone did not affect the TSLP mRNA expression, while pre-incubation of MCs with IL-4 for 48 h significantly enhanced the FcϵRI-mediated TSLP mRNA expression (by 53.7±15.9-fold; p<0.05) and the amount of TSLP in the cell pellets increased significantly from 23.4±4.3 pg·mL−1 to 121.5±3.7 pg·mL−1(p<0.0001). However, the released TSLP was rapidly degraded by proteases that were released by MCs. We identified the population of cells expressing TSLP in the lungs of 16 asthmatic and 11 control subjects by immunohistochemistry. The percentage of TSLP-positive MCs in the total population of MCs was significantly increased in asthmatic airways (p<0.0001). Thus, MCs are able to store TSLP intracellularly and to produce TSLP following aggregation of FcϵRI in the presence of IL-4.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1183/09031936.00121008

Cites

26 of 26 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • TSLP activates dendritic cells, promotes Th2 responses, and activates mast cells.

    “Further, TSLP has been shown to activate dendritic cells, promote Th2 responses, and activate mast cells.401”

    From International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis (2018) · cites this paper as [401]

    The background section states that TSLP activates dendritic cells and promotes DC-mediated Th2 responses. The Discussion reports that TSLP stimulates Th2 cytokine production by human mast cells, but specifies that this occurs synergistically with IL-1 and TNF-α; it does not establish unqualified mast-cell activation by TSLP alone. (LLM, conf=0.82)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. Busse WW, Lemanske RF Jr. Asthma. N Engl J Med 2001; 344: 350-362.

Cited by

Sorted by citations

Authors
Okayama, Y., Okumura, S., Sagara, H., Yuki, K., Sasaki, T., Watanabe, N., Fueki, M., Sugiyama, K., Takeda, K., Fukuda, T., Saito, H., & Ra, C.
Affiliations
  • Nihon University (JP)
  • Stanford Medicine (US)
  • Institute of Medical Science, The University of Tokyo (JP)
  • Juntendo University (JP)
  • National Research Institute for Child Health and Development (JP)
Corresponding author
Okayama, Y.
Venue
European Respiratory Journal
Published
2009-01-22
Volume
34
Issue
2
Pages
425-435
ISSN
  • 0903-1936 (ISSN-L)
  • 1399-3003
OpenAlex
W2160161426
Cited by
100
References
26
Citations by year
2025: 2 · 2024: 4 · 2023: 6 · 2022: 9 · 2021: 4 · 2020: 2 · 2019: 6 · 2018: 11 · 2017: 3 · 2016: 4 · 2015: 6 · 2014: 6 · 2013: 11 · 2012: 7
FWCI
3.73
Type
journal article
Language
en
Open access
Locations
  • European Respiratory Journal (publishedVersion)
  • PubMed (publishedVersion)
Funders
Dokkyo Medical University
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › Mast cells and histamine
  • Health Sciences › Medicine › Physiology › Asthma and respiratory diseases
  • Health Sciences › Medicine › Immunology and Allergy › Allergic Rhinitis and Sensitization
Keywords
thymic stromal lymphopoietin, mast cells, FcεRI, IL-4, asthma, airway inflammation
MeSH terms
Thymic Stromal Lymphopoietin, Adult, Asthma, Bronchi, Female, Humans, Immunohistochemistry, Leukocytes, Mononuclear, Male, Mast Cells, Middle Aged, Interleukin-4, Case-Control Studies, Cytokines, Receptors, IgE, Respiratory Mucosa

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review